Suchergebnisse - "Moss, Ronald B"

PubPharm (98)

1

Brief Report: Higher Fentanyl Exposures Require Higher Doses of Naloxone for Successful Reversals in a Quantitative Systems Pharmacology Model

enthalten in: ResearchSquare.com | 2021

von Moss, R. | Pryor, M. | Baillie, R. | +4

2

Treatment of infection by human enterovirus D68

enthalten in: Europäisches Patentamt | 2021

von MOSS RONALD B

3

TREATMENT FOR BK POLYOMAVIRUS INFECTION

enthalten in: Europäisches Patentamt | 2021

von MOSS RONALD B

4

Brief report : Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients

enthalten in: Clinical immunology (Orlando, Fla.) | 2021

von Mathi, K. | Rosenberg-Hasson, Y. | Maecker, H. | +2

5

EMERGENCY DEVICES

enthalten in: Europäisches Patentamt | 2021

von FLATHER MARK J | DANIELS KAREN K | MOLL THOMAS | +2

6

Emergency devices

enthalten in: Europäisches Patentamt | 2021

von FLATHER MARK J | DANIELS KAREN K | MOLL THOMAS | +2

7

TREATMENT OF INFECTION BY HUMAN ENTEROVIRUS D68

enthalten in: Europäisches Patentamt | 2021

von MOSS RONALD B

8

Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza Patients

enthalten in: Europäisches Patentamt | 2021

von MOSS RONALD B | LI TIEJUN

9

ANTI-VIRAL THERAPEUTIC FOR INFECTION OF THE EYE

enthalten in: Europäisches Patentamt | 2020

von MOSS RONALD B

10

An open-label, randomized, single-dose, two-period, two-treatment crossover bioavailability study comparing 5 mg/0.5 mL of intramuscular naloxone hydrochloride to 2 mg/0.4 mL intramuscular naloxone hydrochloride autoinjector in healthy subjects

enthalten in: Journal of opioid management | 2020

von Moss, R. | Carleton, F. | Lollo, C. | +1

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]